Washington, DC, just decriminalized psychedelic plants. Here’s what happens next
Leafly, November 4, 2020
Residents of the nation’s capital just took a step toward more liberal use of hallucinogens, in response to a groundswell of interest in new drugs for medical maladies.
Oregon Measure 109, Psilocybin Mushroom Services Program Initiative (2020)
Ballotpedia, November 3, 2020
Oregon Measure 109, the Psilocybin Program Initiative was on the ballot in Oregon as an initiated state statute on November 3, 2020. It was approved.
Numinus Becomes The First Canadian Psychedelics Company To Legally Harvest Magic Mushrooms
Forbes, October 23, 2020
A Vancouver-based psychedelics company has become the first in Canada to complete a legal harvest of magic mushrooms since the last wave of psychedelic research ended there in the 1970s.
Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD
MAPS, October 14, 2020
Healthcare cost savings of MDMA-assisted psychotherapy for PTSD estimated to be greater than $(USD)103.2 million with a return of 5,553 Quality of Life Years per 1,000 patients.
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
Plos One, October 14, 2020
Chronic posttraumatic stress disorder (PTSD) is a disabling condition that generates considerable morbidity, mortality, and both medical and indirect social costs. Treatment options are limited. A novel therapy using 3,4-methylenedioxymethamphetamine (MDMA) has shown efficacy in six phase 2 trials. Its cost-effectiveness is unknown.
Are psychedelics the answer to depression and addiction?
Salon, April 22, 2018
A new generation of research into psilocybin could change how we treat numerous mental health conditions.